Patriot Financial Group Insurance Agency’s NovoCure NVCR Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,315	Closed	-$91K	–	1423
2022 Q2	$91K	Sell	1,315 -49	-4%	-$3.69K	0.02%	578
2022 Q1	$113K	Sell	1,364 -15	-1%	-$1.1K	0.02%	550
2021 Q4	$104K	Sell	1,379 -30	-2%	-$3.01K	0.02%	648
2021 Q3	$164K	Sell	1,409 -5	-0.4%	-$756	0.03%	493
2021 Q2	$314K	Buy	1,414 +1,272	+896%	+$247K	0.06%	328
2021 Q1	$19K	Hold	142	–	–	﹤0.01%	1119
2020 Q4	$25K	Hold	142	–	–	0.01%	902
2020 Q3	$16K	Hold	142	–	–	0.01%	886
2020 Q2	$8K	Buy	142 +18	+15%	+$1.18K	﹤0.01%	1044
2020 Q1	$8K	Buy	+124	New	+$9.8K	﹤0.01%	931

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Patriot Financial Group Insurance Agency's NVCR Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of NovoCure (NVCR) in Q3 2022, closing a stake of 1,315 shares — an estimated $91K sold.

Patriot Financial Group Insurance Agency first reported a position in NVCR in Q1 2020 and held it in 10 quarters. The position peaked at $314K in Q2 2021. 304 funds tracked by Wall St. Rank hold NVCR as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining NovoCure position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 1,315 NovoCure shares in Q3 2022, an estimated $91K.
Patriot Financial Group Insurance Agency first reported a position in NovoCure in Q1 2020 and held it in 10 quarters.
Patriot Financial Group Insurance Agency's NovoCure position peaked at $314K in Q2 2021.
304 funds tracked by Wall St. Rank held NovoCure as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.